American National Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
1,778
+82
| +5% | +$6.41K | 0.01% | 284 |
|
|
2025
Q1 | $123K | Buy |
1,696
+7
| +0.4% | +$507 | 0.01% | 254 |
|
|
2024
Q4 | $125K | Hold |
1,689
| – | – | 0.01% | 242 |
|
|
2024
Q3 | $111K | Hold |
1,689
| – | – | 0.01% | 248 |
|
|
2024
Q2 | $156K | Hold |
1,689
| – | – | 0.02% | 228 |
|
|
2024
Q1 | $161K | Hold |
1,689
| – | – | 0.02% | 213 |
|
|
2023
Q4 | $129K | Hold |
1,689
| – | – | 0.02% | 207 |
|
|
2023
Q3 | $117K | Hold |
1,689
| – | – | 0.02% | 208 |
|
|
2023
Q2 | $159K | Hold |
1,689
| – | – | 0.03% | 173 |
|
|
2023
Q1 | $140K | Sell |
1,689
-38
| -2% | -$3.14K | 0.03% | 174 |
|
|
2022
Q4 | $129K | Buy |
1,727
+1,447
| +517% | +$108K | 0.03% | 169 |
|
|
2022
Q3 | $23K | Buy |
280
+56
| +25% | +$4.6K | 0.01% | 300 |
|
|
2022
Q2 | $21K | Sell |
224
-9
| -4% | -$844 | 0.01% | 242 |
|
|
2022
Q1 | $27K | Buy |
233
+116
| +99% | +$13.4K | 0.01% | 244 |
|
|
2021
Q4 | $15K | Buy |
+117
| New | +$15K | ﹤0.01% | 259 |
|